Identification and characterization of host cell protein product‐associated impurities in monoclonal antibody bioprocessing
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Downstream processing of monoclonal antibodies (mAbs) has evolved to allow the specific process for a new product to be developed largely by empirical specialization of a platform process that enables removal of impurities of different kinds. A more complete characterization of impurities and the product itself would provide insights into the rational design of efficient downstream processes. This work identifies and characterizes host cell protein (HCP) product‐associated impurities, that is, HCP species carried through the downstream processes via direct interactions with the mAb. Interactions between HCPs and mAbs are characterized using cross‐interaction chromatography under solution conditions typical of those used in downstream processing. The interacting species are then identified by two‐dimensional gel electrophoresis and mass spectrometry. This methodology has been applied to identify product‐associated impurities in one particular purification step, namely protein A affinity chromatography, for four therapeutic mAbs as well as the Fab and Fc domains of one of these mAbs. The results show both the differences in HCP–mAb interactions among different mAbs, and the relative importance of product association compared to co‐elution in protein A affinity chromatography. Biotechnol. Biotechnol. Bioeng. 2014;111: 904–912. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Therapeutic antibodies: successes, limitations and hopes for the future
Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1932 · Cited by 785
Self-citationImpact of Product-Related Factors on Immunogenicity of Biotherapeutics
Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22276 · Cited by 350
Cited by
Chiu, J., Valente, K. N., Levy, N. E., Min, L., Lenhoff, A. M., & Lee, K. H. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26237 · Cited by 204
“Prior studies explored three routes by which HCP impurities can challenge downstream purification: product-association through strong attractive interactions with mAb products under protein A loading conditions (Levy et al., 2014), variable expression during extended cell culture (Valente et al.”
BackgroundSelf-citationGoey, C. H., Tsang, J. M. H., Bell, D., & Kontoravdi, C. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26437 · Cited by 39
Metadata
- Authors
- Levy, N. E., Valente, K. N., Choe, L. H., Lee, K. H., & Lenhoff, A. M.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2013-12-11
- Volume
- 111
- Issue
- 5
- Pages
- 904-912
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2133776376
- Cited by
- 183
- References
- 4
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.